Articles

GLP‑1 receptor agonists have transformed the way we manage type 2 diabetes and obesity—but could they also play a role in sleep apnea treatment? The intersection of GLP-1 sleep apnea benefits is gaining attention, with new evidence suggesting these therapies may offer more than just weight loss. With diabetes and …

The rise of GLP-1 obesity treatment has transformed how clinicians approach patients with both obesity and diabetes. These therapies, originally developed for glucose control, now show robust benefits in weight management. However, as use becomes more common in clinical practice, endocrinologists and primary care providers must balance glycemic outcomes, weight …

As the landscape of diabetes care evolves, one question continues to surface: are we focusing too much on glucose and not enough on the bigger cardiometabolic picture? In recent years, glucagon‑like peptide‑1 receptor agonists (GLP‑1 RAs) have moved from glucose-focused agents to powerful tools in cardiovascular and metabolic risk reduction. …

Hospital discharge marks a critical juncture in the care of people with diabetes. It’s a period often riddled with risk—confusion about medications, fluctuating blood sugar levels, and a lack of follow-up can easily derail recovery. As clinicians, how can we improve post-discharge outcomes and reduce readmissions? This practical checklist offers …

Living with diabetes can take a serious toll on a person’s mental well-being. Depression, anxiety, and other psychiatric conditions often go hand-in-hand with chronic illnesses, and diabetes is no exception. Yet, despite the deep connection between mental health and diabetes, care for these conditions remains siloed. This article gives clinicians …

By reframing how we discuss medication adherence, clinicians can uncover patient barriers and co-create effective solutions that support long-term diabetes management. Diabetes medication adherence is essential for effective blood glucose control and long-term health outcomes. Yet, for many clinicians, nonadherence is often noted in charts without digging into the real-world …

Did you know that women with diabetes have a significantly higher risk of heart disease compared to men with diabetes? While many of the standard care guidelines apply to all patients, women often face additional, underrecognized threats to their heart and metabolic health. Understanding how sex-specific factors—such as hormonal changes, …

  As the burden of diabetic kidney disease (DKD) continues to grow, so does the urgency for early, evidence-based interventions. The concept of kidney protection diabetes is shifting—clinicians are now encouraged to initiate therapy before substantial kidney function loss occurs. Two major drug classes—SGLT2 inhibitors and GLP‑1 receptor agonists—are leading …

Could metabolic surgery be the turning point for your patients with type 2 diabetes who aren’t seeing results with medication alone? As evidence mounts around the success of metabolic surgery type 2 diabetes treatment, more clinicians are exploring when and how to refer patients. This guide explains who qualifies, what …

As diabetes technology advances, hybrid closed‑loop systems are no longer exclusive to type 1 diabetes. In recent years, their use in insulin-treated type 2 diabetes has gained attention. These systems promise better glucose control and improved quality of life by automating much of the insulin delivery process. But are they …